2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Spondylitis, Ankylosing
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Pain, Postoperative
1
Lymphoma, Follicular
1
Hodgkin Disease
1
Chronic Pain
1
Acute Pain
1
Interventions
Ketamine
4
Surveys and Questionnaires
3
Oxycodone
2
Gabapentin
2
Diclofenac
2
Anesthesia, General
2
Acetaminophen
2
Transcutaneous Electric Nerve Stimulation
1
Tea
1
Ropivacaine
1
Quality of Life
1
Psychotherapy
1
Pregabalin
1
Passive Cutaneous Anaphylaxis
1
Minocycline
1
Meloxicam
1
Lidocaine
1
Ketorolac Tromethamine
1
Ketorolac
1
Ibuprofen
1
Hydromorphone
1
Fentanyl
1
Ethyl Chloride
1
Epinephrine
1
Duloxetine Hydrochloride
1
Diathermy
1
Dexmedetomidine
1
Cryotherapy
1
Control Groups
1
Circumcision, Male
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acute Pain
×
Meloxicam
×
Clear all
NCT01789216
2021-02-03
PAIN
Major Extremity Trauma Research Consortium
Phase 3
Completed
450 enrolled